RIOXF(RIOXF)
USD --+0.00%
Reward53Moderate
Risk32Moderate
📊75%Data
3.3% dividend yield · Revenue down 7% YoY
RIOXF
+0.0 · +0.00%
USD · PINK
RIOXF | Healthcare
Dividend King
Market Cap:180.39M
ℹ️
Reward Rating
53
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
32
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on RIOXF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is RIOXF?

develops, manufactures, sells, and services particle counters, medical equipment, and environmental equipment in Japan.

RIOXF · Verdict

Moderate reward · moderate risk

RIOXF scores well on volatility and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

RIOXF · Verdict

What’s working & what to watch

Strengths 3

  • Volatility80/100

    Top decile vs peers

  • Cash flow76/100

    7% free-cash-flow margin

  • Valuation70/100

    Above average

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is RIOXF?

develops, manufactures, sells, and services particle counters, medical equipment, and environmental equipment in Japan. The company's audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom-made, and analog body aid instruments, as well as wireless and waterproof hearing instruments; and medical equipment comprising audiometers and OAE screeners. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 180.39M, and a P/E ratio of 9.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (53)

The scoring profile indicates limited reward potential at this time, with valuation and profitability offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap180.39M
P/E Ratio9.2595
Dividend Yield3.33%
52 Week High19.4189
52 Week Low14.3847
Last AnnualMarch
IPO DateN/A
IncorporatedUSA
Shares Outstanding12M
No. of Employees1,009
IndustryMedical Devices
ExchangePINK
Beta0.357
CurrencyUSD · Reports in JPY